Rising tides: Avant eyes retail launch of cell-based fish maw and fillet by 2025 - CEO interview
Hong Kong’s cultivated meat biotechnology firm Avant is aiming to produce its first cell-based fish maw and fillet products for consumption by late 2022, and wants products to be commonplace in supermarkets by 2025.
It first launched the cell-based fish maw prototype in 2019, and the cell-based fish fillet in 2020, and now hopes to manufacture these in a soon-to-be set up pilot plant in Singapore by late 2022.
Once it receives approval from Singapore’s regulatory body, the Singapore Food Agency (SFA), Avant will initially produce for foodservice first, and target the larger retail sector sometime in 2025.